NACDS RxIMPACT Day on Capitol Hill will keep DIR fee reform front-and-center
In just over two weeks, pharmacy advocates from all 50 states will travel to Washington, D.C. for NACDS RxIMPACT Day on Capitol Hill.
Bill Schiffner
Breakthrough Psoriasis treatment looks to bring top results to skin care market
After five years of design, two years in development, and now shipping thousands of units to customers, breakthrough psoriasis treatment Prosoria is poised to make its mark in the over-the-counter skin care market.
Hy-Vee dietitians to provide free biometric screenings in February
For the second year, Hy-Vee, Inc. will be providing free biometric screenings throughout its eight-state region during Heart Health Month in February. Hy-Vee dietitians working out of Hy-Vee Healthy You Mobiles will offer the free biometric screenings to customers at 150 Hy-Vee stores.
Canada’s pharmacy sector holding strong
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. Looking ahead to 2019, the pharmacy business is poised to be more disrupted than ever before.
Putting patients first and encouraging innovation
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. For much of 2018, capital markets for biotech investment were strong. Some 53 biotech companies went public with more than $5.
Making the Rx markets more competitive again
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. This past June, Secretary of Health and Human Services Alex Azar told the Senate Finance Committee, “We need a strong, robust generic market.
An introduction to the coming cannabis ‘gold rush’
Editor’s note: This is Part I of an article that ran in the 1/21/19 issue of CDR.
Nebraska, New Mexico the top areas in Walgreens Flu Index
Nebraska, New Mexico and Kentucky are in the top slots for State Flu Activity in Walgreens Flu Index for the week ending January 12, 2019.
Making health care work better for patients
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. Pharmacists are medication experts. Every day, they get to see the remarkable difference innovative treatments can make in their customers’ lives.
Pharmacy payment model needs to be simplified
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. One thing that can be said about the state of prescription medications in 2019 is that the pharmacy payment model is complex, convoluted and confusing.
NACDS’ Anderson sets agenda for 2019
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. In health policy, 2018 and 2019 could look a lot alike.
Value-based contracts provide promise and potential
There has been significant focus and attention paid to the issue of drug prices in the last few years. As Adam Fein, president of Pembroke Consulting Inc. and chief executive officer of Drug Channels Institute, has said, “Drugs are 12% of the costs, but 90% of the conversation.
Branded prescription drug spend — A basic framework
Drug prices are a major target of patient groups and Congress, although drug spending makes up only 10% of the $3.3 trillion spent on U.S. health care in a year.
Acosta reveals top 10 CPG industry predictions for 2019
The consumer packaged goods industry is rapidly evolving, and a New Year will usher in even more changes.
Probiotics: Your secret weapon for cold and flu season
For us, alerting our patients to new ways to boost immunity or rebound from illness quickly is one of the best parts of the job.
Diabetes increases risk for liver disease
Nonalcoholic fatty liver disease (NAFLD) is an asymptomatic disease that affects about 100 million Americans. Being overweight, obese or diabetic are primary risk factors for NAFLD, an umbrella term describing those liver diseases that aren’t related to alcohol consumption.